Epithalon 10MG

Epithalon is the alternate nomenclature for the same Ala-Glu-Asp-Gly tetrapeptide marketed as Epitalon — the two names reflect transliteration differences from the original Russian research literature rather than any chemical distinction. That literature, emerging from the St. Petersburg school of peptide bioregulation, proposed that ultra-short peptides could act as tissue-specific gene-expression modulators, a hypothesis that continues to generate both interest and debate in peptide science. In laboratory practice, Epithalon is studied in the same domains as its twin-named counterpart: telomere-maintenance models, pineal and circadian biology, and comparative panels of short regulatory peptides. Researchers working with it typically focus on in vitro endpoints — gene-expression readouts, telomerase-activity assays, and cell-viability models — where the compound's minimal structure simplifies interpretation. This 10MG format is suited to pilot investigations and inclusion in broader bioregulator screening programs. Transliteration variants in the literature mean researchers should verify they are comparing equivalent materials when reviewing published data. For laboratory research use only. Not for human or veterinary use.